Share This
The FINANCIAL In a major boost to efforts to combat COVID-19 globally, a vaccine that recently entered human trials in Vietnam and Thailand, and is slated for a clinical study in Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines. The vaccine is the result of a partnership between The University of Texas at Austin, the Icahn School of Medicine at Mount Sinai in New York and global partners interested in advancing the supply of affordable vaccines to address the pandemic.
The vaccine, NDV-HXP-S, can be stored at 2-8 degrees Celsius and is made in eggs, a method also used for flu vaccine manufacturing. These factors mean that affordable manufacturing capacity already exists in each of the countries involved with trials, The University of Texas at Austin notes.
Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The FINANCIAL - Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access
finchannel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finchannel.com Daily Mail and Mail on Sunday newspapers.